Literature DB >> 7917863

Clinical observations on the use of the Chinese herb Tripterygium wilfordii Hook for the treatment of nephrotic syndrome.

X Jiang1.   

Abstract

A preparation of extracts from the root of the Chinese medicinal herb Tripterygium wilfordii Hook was administered orally at a dose of 1 mg/kg body weight per day to 13 children with idiopathic nephrotic syndrome. Eight children, including 4 who were steroid resistant, went into remission which was maintained in 4 for up to 3 years after withdrawal of treatment. In 3 children the proteinuria lessened with the return of plasma protein concentration to normal, and in 1 child this improvement was maintained for 4 years after treatment ceased. No serious side-effects were noted, but a temporary anti-fertility activity has been noted in other studies of both men and women.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917863     DOI: 10.1007/bf00866356

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.

Authors:  Mei Huang; Hailong Zhang; Tao Liu; Dan Tian; Lubing Gu; Muxiang Zhou
Journal:  Mol Cancer Ther       Date:  2012-12-12       Impact factor: 6.261

2.  MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer.

Authors:  Aimin Yang; Shenghui Qin; Bradley A Schulte; Stephen P Ethier; Kenneth D Tew; Gavin Y Wang
Journal:  Cancer Res       Date:  2017-09-26       Impact factor: 12.701

Review 3.  Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases.

Authors:  Rui Han; Martin Rostami-Yazdi; Sascha Gerdes; Ulrich Mrowietz
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

4.  Triptolide inhibits IL-12/IL-23 expression in APCs via CCAAT/enhancer-binding protein alpha.

Authors:  Yan Zhang; Xiaojing Ma
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

5.  The roles of endogenous reactive oxygen species and nitric oxide in triptolide-induced apoptotic cell death in macrophages.

Authors:  Xiaofeng Bao; Jun Cui; Yuanyuan Wu; Xiaodong Han; Cheng Gao; Zichun Hua; Pingping Shen
Journal:  J Mol Med (Berl)       Date:  2006-11-16       Impact factor: 4.599

6.  Clinical outcomes in children with Henoch-Schönlein purpura nephritis grade IIIa or IIIb.

Authors:  Yonghui Xia; Jianhua Mao; Yifang Chen; Dayan Wang; Lu Cao; Shenhua Yao; Haidong Fu; Lizhong Du; Ai'min Liu
Journal:  Pediatr Nephrol       Date:  2011-03-09       Impact factor: 3.714

Review 7.  Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8).

Authors:  Wei Tang; Jian-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

8.  Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells.

Authors:  Bing Z Carter; Duncan H Mak; Wendy D Schober; Teresa McQueen; David Harris; Zeev Estrov; Randall L Evans; Michael Andreeff
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

9.  Identification of geranylgeranyl diphosphate synthase genes from Tripterygium wilfordii.

Authors:  Meng Zhang; Ping Su; Yong-Jin Zhou; Xiu-Juan Wang; Yu-Jun Zhao; Yu-Jia Liu; Yu-Ru Tong; Tian-Yuan Hu; Lu-Qi Huang; Wei Gao
Journal:  Plant Cell Rep       Date:  2015-10-08       Impact factor: 4.570

10.  Drugs controlling proteinuria of patients with Alport syndrome.

Authors:  Jian-Guo Li; Jie Ding; Fang Wang; Hong-Wen Zhang
Journal:  World J Pediatr       Date:  2009-11-13       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.